Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Cash & Equivalents (2016 - 2026)

Cryoport has reported Cash & Equivalents over the past 17 years, most recently at $272.9 million for Q1 2026.

  • Quarterly Cash & Equivalents rose 476.24% to $272.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $272.9 million through Mar 2026, up 476.24% year-over-year, with the annual reading at $250.5 million for FY2025, 633.79% up from the prior year.
  • Cash & Equivalents was $272.9 million for Q1 2026 at Cryoport, up from $250.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $272.9 million in Q1 2026 and troughed at $28.9 million in Q3 2022.
  • The 5-year median for Cash & Equivalents is $39.3 million (2024), against an average of $95.6 million.
  • Year-over-year, Cash & Equivalents plummeted 89.4% in 2022 and then skyrocketed 715.57% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $36.6 million in 2022, then increased by 26.65% to $46.3 million in 2023, then fell by 26.34% to $34.1 million in 2024, then skyrocketed by 633.79% to $250.5 million in 2025, then increased by 8.95% to $272.9 million in 2026.
  • Per Business Quant, the three most recent readings for CYRX's Cash & Equivalents are $272.9 million (Q1 2026), $250.5 million (Q4 2025), and $255.8 million (Q3 2025).